Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Human Neural Stem Cells (ANGE-S003) Nasal Delivery in Parkinson's Disease
NCT03128450Phase 3Unknown
- Sponsor
- The Second Affiliated Hospital of Soochow University
- Start
- Apr 2017
- Primary completion
- Jun 2018
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial in Parkinson's disease (PD), sponsored by The Second Affiliated Hospital of Soochow University. Primary endpoint: Unified Parkinson's Disease Rating Scale at 28 weeks. Status: unknown.
02
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on NCT03128450.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03128450.